BIOMARIN PHARMACEUTICAL INC Earnings Per Share (Diluted)
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Earnings Per Share (Diluted) of $0.23 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC earnings per share, diluted for the quarter ending 2026-06-30 was $0.23, a 81.30% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC earnings per share, diluted for the quarter ending 2026-03-31 was $0.54, a 43.16% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC earnings per share, diluted for the quarter ending 2025-12-31 was -$0.22, a 134.91% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC earnings per share, diluted for the quarter ending 2025-09-30 was -$0.16, a 129.09% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC earnings per share, diluted for fiscal 2025 was $1.80, a 18.55% decline from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC earnings per share, diluted for fiscal 2024 was $2.21, a 154.02% increase from fiscal 2023.
- BIOMARIN PHARMACEUTICAL INC earnings per share, diluted for fiscal 2023 was $0.87, a 16.00% increase from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC earnings per share, diluted for fiscal 2022 was $0.75.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.23 10-Q · filed 2026-08-06 | $0.77 10-Q · filed 2026-08-06 | $0.55 derived: net income ÷ weighted average shares · filed 2026-08-06 | $0.39 derived: net income ÷ weighted average shares · filed 2026-08-06 | |||
| 2026-03-31 | $0.54 10-Q · filed 2026-05-05 | $0.32 derived: net income ÷ weighted average shares · filed 2026-05-05 | $0.16 derived: net income ÷ weighted average shares · filed 2026-05-05 | $1.40 derived: net income ÷ weighted average shares · filed 2026-08-06 | |||
| 2025-12-31 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-02-26 | $0.85 derived: net income ÷ weighted average shares · filed 2026-08-06 | $1.80 10-K · filed 2026-02-26 | |||
| 2025-09-30 | -$0.16 10-Q · filed 2025-10-28 | $1.09 derived: net income ÷ weighted average shares · filed 2026-08-06 | $2.04 10-Q · filed 2025-10-28 | $2.69 derived: net income ÷ weighted average shares · filed 2026-08-06 | |||
| 2025-06-30 | $1.23 10-Q · filed 2026-08-06 | $2.19 10-Q · filed 2026-08-06 | $2.83 derived: net income ÷ weighted average shares · filed 2026-08-06 | $3.38 derived: net income ÷ weighted average shares · filed 2026-08-06 | |||
| 2025-03-31 | $0.95 10-Q · filed 2026-05-05 | $1.60 derived: net income ÷ weighted average shares · filed 2026-05-05 | $2.15 derived: net income ÷ weighted average shares · filed 2026-05-05 | $2.69 derived: net income ÷ weighted average shares · filed 2026-05-05 | |||
| 2024-12-31 | $0.64 derived: net income ÷ weighted average shares · filed 2026-02-26 | $1.19 derived: net income ÷ weighted average shares · filed 2026-02-26 | $1.74 derived: net income ÷ weighted average shares · filed 2026-02-26 | $2.21 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $0.55 10-Q · filed 2025-10-28 | $1.10 derived: net income ÷ weighted average shares · filed 2025-10-28 | $1.56 10-Q · filed 2025-10-28 | $1.68 derived: net income ÷ weighted average shares · filed 2026-02-26 | |||
| 2024-06-30 | $0.55 10-Q · filed 2025-08-05 | $1.01 10-Q · filed 2025-08-05 | $1.13 derived: net income ÷ weighted average shares · filed 2026-02-26 | $1.34 derived: net income ÷ weighted average shares · filed 2026-02-26 | |||
| 2024-03-31 | $0.46 10-Q · filed 2025-05-02 | $0.57 derived: net income ÷ weighted average shares · filed 2026-02-26 | $0.78 derived: net income ÷ weighted average shares · filed 2026-02-26 | $1.08 derived: net income ÷ weighted average shares · filed 2026-02-26 | |||
| 2023-12-31 | $0.10 derived: net income ÷ weighted average shares · filed 2026-02-26 | $0.31 derived: net income ÷ weighted average shares · filed 2026-02-26 | $0.61 derived: net income ÷ weighted average shares · filed 2026-02-26 | $0.87 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $0.21 10-Q · filed 2024-10-31 | $0.50 derived: net income ÷ weighted average shares · filed 2024-10-31 | $0.77 10-Q · filed 2024-10-31 | $0.77 derived: net income ÷ weighted average shares · filed 2025-02-24 | |||
| 2023-06-30 | $0.29 10-Q · filed 2024-08-05 | $0.56 10-Q · filed 2024-08-05 | $0.56 derived: net income ÷ weighted average shares · filed 2025-02-24 | $0.53 derived: net income ÷ weighted average shares · filed 2025-02-24 | |||
| 2023-03-31 | $0.27 10-Q · filed 2024-04-26 | $0.26 derived: net income ÷ weighted average shares · filed 2025-02-24 | $0.23 derived: net income ÷ weighted average shares · filed 2025-02-24 | $0.37 derived: net income ÷ weighted average shares · filed 2025-02-24 | |||
| 2022-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2025-02-24 | -$0.05 derived: net income ÷ weighted average shares · filed 2025-02-24 | $0.10 derived: net income ÷ weighted average shares · filed 2025-02-24 | $0.75 10-K · filed 2025-02-24 | |||
| 2022-09-30 | -$0.04 10-Q · filed 2023-11-02 | $0.11 derived: net income ÷ weighted average shares · filed 2023-11-02 | $0.75 10-Q · filed 2023-11-02 | $0.46 derived: net income ÷ weighted average shares · filed 2024-02-26 | |||
| 2022-06-30 | $0.15 10-Q · filed 2023-08-02 | $0.79 10-Q · filed 2023-08-02 | $0.49 derived: net income ÷ weighted average shares · filed 2024-02-26 | $0.30 derived: net income ÷ weighted average shares · filed 2024-02-26 | |||
| 2022-03-31 | $0.63 10-Q · filed 2023-04-28 | $0.35 derived: net income ÷ weighted average shares · filed 2024-02-26 | $0.16 derived: net income ÷ weighted average shares · filed 2024-02-26 | $0.23 derived: net income ÷ weighted average shares · filed 2024-02-26 | |||
| 2021-12-31 | -$0.32 derived: net income ÷ weighted average shares · filed 2024-02-26 | -$0.51 derived: net income ÷ weighted average shares · filed 2024-02-26 | -$0.44 derived: net income ÷ weighted average shares · filed 2024-02-26 | -$0.35 10-K · filed 2024-02-26 | |||
| 2021-09-30 | -$0.20 10-Q · filed 2022-10-28 | -$0.13 derived: net income ÷ weighted average shares · filed 2022-10-28 | -$0.03 10-Q · filed 2022-10-28 | $0.00 derived: net income ÷ weighted average shares · filed 2023-02-27 | |||
| 2021-06-30 | $0.07 10-Q · filed 2022-08-04 | $0.16 10-Q · filed 2022-08-04 | $0.20 derived: net income ÷ weighted average shares · filed 2023-02-27 | $4.43 derived: net income ÷ weighted average shares · filed 2023-02-27 | |||
| 2021-03-31 | $0.09 10-Q · filed 2022-04-29 | $0.13 derived: net income ÷ weighted average shares · filed 2023-02-27 | $4.34 derived: net income ÷ weighted average shares · filed 2023-02-27 | $4.23 derived: net income ÷ weighted average shares · filed 2023-02-27 | |||
| 2020-12-31 | $0.04 derived: net income ÷ weighted average shares · filed 2023-02-27 | $4.21 derived: net income ÷ weighted average shares · filed 2023-02-27 | $4.12 derived: net income ÷ weighted average shares · filed 2023-02-27 | $4.50 10-K · filed 2023-02-27 | $4.53 10-K · filed 2021-02-26 | ||
| 2020-09-30 | $4.01 10-Q · filed 2021-10-29 | $4.03 derived: net income ÷ weighted average shares · filed 2021-10-29 | $4.39 10-Q · filed 2021-10-29 | $4.62 derived: net income ÷ weighted average shares · filed 2022-02-25 | |||
| 2020-06-30 | -$0.16 10-Q · filed 2021-07-30 | $0.28 10-Q · filed 2021-07-30 | $0.37 derived: net income ÷ weighted average shares · filed 2022-02-25 | $0.68 derived: net income ÷ weighted average shares · filed 2022-02-25 | |||
| 2020-03-31 | $0.44 10-Q · filed 2021-04-30 | $0.53 derived: net income ÷ weighted average shares · filed 2022-02-25 | $0.83 derived: net income ÷ weighted average shares · filed 2022-02-25 | ||||
| 2019-12-31 | $0.08 derived: net income ÷ weighted average shares · filed 2022-02-25 | $0.39 derived: net income ÷ weighted average shares · filed 2022-02-25 | -$0.13 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $0.30 10-Q · filed 2020-11-06 | -$0.22 10-Q · filed 2020-11-06 | |||||
| 2019-06-30 | -$0.21 10-Q · filed 2020-08-05 | -$0.53 10-Q · filed 2020-08-05 | |||||
| 2019-03-31 | -$0.32 10-Q · filed 2020-05-01 | -$0.34 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$0.41 derived: net income ÷ weighted average shares · filed 2021-02-26 | ||||
| 2018-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$0.10 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$0.44 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | -$0.07 10-Q/A · filed 2019-11-04 | -$0.42 10-Q/A · filed 2019-11-04 | |||||
| 2018-03-31 | -$0.26 10-Q · filed 2019-04-29 | -$0.55 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$0.62 derived: net income ÷ weighted average shares · filed 2020-02-27 | ||||
| 2017-12-31 | -$0.29 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$0.36 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$0.67 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | -$0.07 10-Q · filed 2017-10-31 | -$0.38 10-Q · filed 2017-10-31 | |||||
| 2017-03-31 | -$0.09 10-Q · filed 2018-04-27 | -$0.63 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$0.85 derived: net income ÷ weighted average shares · filed 2019-02-28 | ||||
| 2016-12-31 | -$0.54 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$0.76 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$3.81 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | -$0.22 10-Q · filed 2017-10-31 | -$0.26 10-Q · filed 2016-11-03 | -$3.30 10-Q · filed 2017-10-31 | -$3.37 10-Q · filed 2016-11-03 | |||
| 2015-12-31 | $0.43 derived: net income ÷ weighted average shares · filed 2018-02-26 | -$0.17 derived: net income ÷ weighted average shares · filed 2018-02-26 | -$0.68 derived: net income ÷ weighted average shares · filed 2018-02-26 | -$1.07 10-K · filed 2018-02-26 | |||
| 2015-09-30 | -$0.60 10-Q · filed 2016-11-03 | -$1.11 derived: net income ÷ weighted average shares · filed 2016-11-03 | -$1.51 10-Q · filed 2016-11-03 | -$2.01 derived: net income ÷ weighted average shares · filed 2017-02-27 | |||
| 2015-06-30 | -$0.51 10-Q · filed 2015-08-05 | -$0.94 10-Q · filed 2015-08-05 | -$1.41 derived: net income ÷ weighted average shares · filed 2017-02-27 | -$1.35 derived: net income ÷ weighted average shares · filed 2017-02-27 | |||
| 2015-03-31 | -$0.43 10-Q · filed 2015-05-05 | -$0.90 derived: net income ÷ weighted average shares · filed 2017-02-27 | -$0.84 derived: net income ÷ weighted average shares · filed 2017-02-27 | -$1.07 derived: net income ÷ weighted average shares · filed 2017-02-27 | |||
| 2014-12-31 | -$0.47 derived: net income ÷ weighted average shares · filed 2017-02-27 | -$0.40 derived: net income ÷ weighted average shares · filed 2017-02-27 | -$0.64 derived: net income ÷ weighted average shares · filed 2017-02-27 | -$0.92 10-K · filed 2017-02-27 | |||
| 2014-09-30 | $0.05 10-Q · filed 2015-11-02 | -$0.17 derived: net income ÷ weighted average shares · filed 2015-11-02 | -$0.44 10-Q · filed 2015-11-02 | ||||
| 2014-06-30 | -$0.23 10-Q · filed 2015-08-05 | -$0.50 10-Q · filed 2015-08-05 | |||||
| 2014-03-31 | -$0.27 10-Q · filed 2015-05-05 | ||||||
| 2013-09-30 | -$0.38 10-Q · filed 2014-10-28 | -$0.54 derived: net income ÷ weighted average shares · filed 2014-10-28 | -$0.84 10-Q · filed 2014-10-28 | ||||
| 2013-06-30 | -$0.16 10-Q · filed 2014-07-31 | -$0.46 10-Q · filed 2014-07-31 | |||||
| 2013-03-31 | -$0.31 10-Q · filed 2014-05-02 | ||||||
| 2012-12-31 | -$0.95 10-K · filed 2013-02-26 | ||||||
| 2012-06-30 | -$0.27 10-Q · filed 2013-07-29 | -$0.48 10-Q · filed 2013-07-29 | -$0.71 derived: net income ÷ weighted average shares · filed 2013-07-29 | -$0.87 derived: net income ÷ weighted average shares · filed 2013-07-29 | |||
| 2012-03-31 | -$0.21 10-Q · filed 2012-04-30 | -$0.44 derived: net income ÷ weighted average shares · filed 2013-02-26 | -$0.60 derived: net income ÷ weighted average shares · filed 2013-02-26 | -$0.65 derived: net income ÷ weighted average shares · filed 2013-02-26 | |||
| 2011-12-31 | -$0.23 derived: net income ÷ weighted average shares · filed 2013-02-26 | -$0.39 derived: net income ÷ weighted average shares · filed 2013-02-26 | -$0.44 derived: net income ÷ weighted average shares · filed 2013-02-26 | -$0.48 10-K · filed 2013-02-26 | |||
| 2011-09-30 | -$0.16 10-Q · filed 2011-10-31 | -$0.20 derived: net income ÷ weighted average shares · filed 2011-10-31 | -$0.24 10-Q · filed 2011-10-31 | -$0.33 derived: net income ÷ weighted average shares · filed 2013-02-26 | |||
| 2011-06-30 | -$0.05 10-Q · filed 2011-08-01 | -$0.09 10-Q · filed 2011-08-01 | -$0.17 derived: net income ÷ weighted average shares · filed 2013-02-26 | $1.74 derived: net income ÷ weighted average shares · filed 2013-02-26 | |||
| 2011-03-31 | -$0.04 10-Q · filed 2012-04-30 | -$0.13 derived: net income ÷ weighted average shares · filed 2013-02-26 | $1.76 derived: net income ÷ weighted average shares · filed 2013-02-26 | $1.81 derived: net income ÷ weighted average shares · filed 2013-02-26 | |||
| 2010-12-31 | -$0.09 derived: net income ÷ weighted average shares · filed 2013-02-26 | $1.74 derived: net income ÷ weighted average shares · filed 2013-02-26 | $1.83 derived: net income ÷ weighted average shares · filed 2013-02-26 | $1.73 10-K · filed 2013-02-26 | |||
| 2010-09-30 | $1.68 10-Q · filed 2011-10-31 | $1.88 derived: net income ÷ weighted average shares · filed 2011-10-31 | $1.74 10-Q · filed 2011-10-31 | ||||
| 2010-06-30 | -$0.01 10-Q · filed 2011-08-01 | $0.01 10-Q · filed 2011-08-01 | |||||
| 2009-12-31 | $0.00 10-K · filed 2012-02-22 | ||||||
| 2009-09-30 | $0.07 10-Q · filed 2010-10-29 | -$0.05 10-Q · filed 2010-10-29 | |||||
| 2009-06-30 | $0.01 10-Q · filed 2010-08-04 | -$0.12 10-Q · filed 2010-08-04 | |||||
| 2008-12-31 | $0.29 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |